Erythrocyte aggregation and metabolic syndrome

Prajwal Gyawali, Ross S. Richards, Diane L. Hughes, Paul Tinley

Research output: Contribution to journalArticle

22 Citations (Scopus)
12 Downloads (Pure)

Abstract

Erythrocyte aggregation has been consistently associated with insulin resistance, central obesity and hypertension in the literature. Oxidative stress and chronic inflammation are almost always present in metabolic syndrome (MetS). Prooxidants and adipocytokines generated in MetS alter erythrocyte morphology, decrease erythrocyte deformability and increase whole blood viscosity (WBV). Increased WBV has been attributed to erythrocyte aggregation which in turn is greatly influenced by other rheological parameters, including its membrane surface charge and plasma fibrinogen concentration. The interplay of hemorheological factors, oxidative stress and inflammation has a detrimental effect in MetS due to the gross disturbance in microcirculation. The hemodynamic aspect of MetS needs further research and exploration
Original languageEnglish
Pages (from-to)73-83
Number of pages11
JournalClinical Hemorheology and Microcirculation
Volume57
Issue number1
DOIs
Publication statusPublished - 2014

Fingerprint Dive into the research topics of 'Erythrocyte aggregation and metabolic syndrome'. Together they form a unique fingerprint.

Cite this